Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Many diet trends have come and go, but intermittent fasting (IF) seems to be here to stay. That's not only because many people have found success with weight loss through IF but also due to the many ...

Limiting the amount of time you can eat per day seems like a surefire way to lose weight—but experts have warned that intermittent fasting (IF) only works if you're sticking to a calorie deficit.

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Ianalumab, an investigational fully human monoclonal antibody drug being studied for its potential to treat various B cell-driven autoimmune diseases, received a Breakthrough Therapy designation for ...

Oculis Holding (OCS) added ~11% on Tuesday after the Swiss drug developer announced the breakthrough therapy designation for its eye disease therapy Privosegtor as a treatment for optic neuritis (ON), ...

Please provide your email address to receive an email when new articles are posted on . If approved, privosegtor would become the first neuroprotective therapy for optic neuropathies. The PIONEER 1 ...

Breakthrough Therapy Designation granted to zoldonrasib for the treatment of adult patients with KRAS G12D-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have been ...

Eli Lilly has won U.S. Food and Drug Administration breakthrough -therapy designation for its sofetabart mipitecan drug candidate for certain patients with ovarian cancer. Eli Lilly on Tuesday said ...

LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- TCL, a global leader in consumer electronics and the world's No. 1 Mini LED and ultra-large TV brand, received multiple prestigious accolades at the 2025–2026 ...

NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...